1. "Urology"
Formats
  1. Journal Article (3000)
  2. Meeting Abstract (1004)
  3. Book Section (177)
  4. Editorial (93)
  5. Review (87)
  6. Correspondence (45)
  7. Conference Paper (33)
  8. Guidelines (33)
  9. Book Whole (18)
  10. Research Letter (12)
  11. Miscellaneous (5)
Groups
  1. Surgery (4507)
  2. Urology (4507)
  3. Population Sciences Research Program (1155)
  4. Epidemiology and Biostatistics (1046)
  5. Department of Medicine (855)
  6. Solid Tumor Oncology Division (807)

More Groups

People
  1. Peter Scardino (671)
  2. John Mulhall (601)
  3. Harry Herr (594)
  4. Paul Russo (581)
  5. James Eastham (537)
  6. Victor Reuter (474)

More People

Years
  1. 2025 (63)
  2. 2024 (163)
  3. 2023 (142)
  4. 2022 (160)
  5. 2021 (175)
  6. 2020 (174)

More Years

Publications
  1. Journal of Urology (538)
  2. Journal of Clinical Oncology (392)
  3. Journal of Sexual Medicine (373)
  4. European Urology (314)
  5. Urology (245)
  6. BJU International (227)

More Publications

Publishers
  1. Elsevier Science, Inc. (1158)
  2. Elsevier Inc. (637)
  3. American Society of Clinical Oncology (403)
  4. Wiley Blackwell (388)
  5. Nature Publishing Group (257)
  6. Springer (213)

More Publishers

Results (4507)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How should molecular markers and magnetic resonance imaging be used in the early detection of prostate cancer?
    Editorial

    Vickers, A. J.; Russo, G.; Lilja, H.; Evans, C.; Schalken, J. A.; Klein, E.; Eggener, S.
    European Urology Oncology (2022)

    Fulltext@MSK | Save
  • Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas
    Journal Article

    Yoo, A.; Tang, C.; Zucker, M.; Fitzgerald, K.; DiNatale, R. G.; Rappold, P. M.; Weiss, K.; Freeman, B.; Lee, C. H.; Schultz, N.; more...
    European Urology Focus (2022)

    Fulltext@MSK | Save
  • Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial
    Meeting Abstract

    Motzer, R. J.; Russo, P.; Gruenwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O. A.; Buti, S.; Barthelemy, P.; Goh, J. C. H.; Ye, D.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Prostate cancer screening with PSA and MRI followed by targeted biopsy only
    Journal Article

    Hugosson, J.; Månsson, M.; Wallström, J.; Axcrona, U.; Carlsson, S. V.; Egevad, L.; Geterud, K.; Khatami, A.; Kohestani, K.; Pihl, C. G.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Prostate cancer, version 1.2023: Featured updates to the NCCN Guidelines
    Guidelines

    Schaeffer, E. M.; Srinivas, S.; Adra, N.; An, Y.; Barocas, D.; Bitting, R.; Bryce, A.; Chapin, B.; Cheng, H. H.; D'Amico, A. V.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade
    Journal Article

    Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Journal Article

    Clinton, T. N.; Chen, Z.; Wise, H.; Lenis, A. T.; Chavan, S.; Donoghue, M. T. A.; Almassi, N.; Chu, C. E.; Dason, S.; Rao, P.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Association of prostate-specific antigen levels with prostate cancer risk in a multiethnic population: Stability over time and comparison with polygenic risk score
    Journal Article

    Chou, A.; Darst, B. F.; Wilkens, L. R.; Marchand, L. L.; Lilja, H.; Conti, D. V.; Haiman, C. A.
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save